Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Boost Vaccination Improves Humoral Immune Response Against Influenza Virus In Patients With Multiple Myeloma

Michael Hahn, Paul Schnitzler, MD, Brunhilde Schweiger, Cathrin Hollenbach, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, MD, Michael Schmitt

Blood (2013) 122 (21): 3206.

https://doi.org/10.1182/blood.V122.21.3206.3206

Published: 2013

Journal Articles

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV

Blood (2011) 118 (21): 781.

https://doi.org/10.1182/blood.V118.21.781.781

Published: 2011

Journal Articles

Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV,

Blood (2011) 118 (21): 3762.

https://doi.org/10.1182/blood.V118.21.3762.3762

Published: 2011

Journal Articles

Endothelial Stress in Steroid-Refractory Gvhd: A Burden Statins Cannot Lift

Sascha Dietrich, MD, Axel Benner, Dipl.Stat, Christine Falk, Michael Hess, Mindaugas Andrulis, Berend H. Isermann, MD, Anthony D. Ho, MD, PhD, Peter Dreger, MD, Thomas Luft

Blood (2011) 118 (21): 1012.

https://doi.org/10.1182/blood.V118.21.1012.1012

Published: 2011

Journal Articles

Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results

Andreas Engert, MD, Heinz Haverkamp, Carsten Kobe, MD, Jana Markova, MD, Christoph Renner, MD, Anthony D. Ho, MD, PhD, Josée Zijlstra, MD, Zdenek Král, MD, Harald Stein, MD, Hans Theodor Eich, MD, Rolf-Peter Müller, MD, Markus Dietlein, MD, Peter Borchmann, MD, Volker Diehl, MD

Blood (2011) 118 (21): 589.

https://doi.org/10.1182/blood.V118.21.589.589

Published: 2011

Journal Articles

Cellular Interaction Between Human Mesenchymal Stem Cells and Hematopoietic Stem Cells in 2D- and 3D-Culture-Systems.

Patrick Wuchter, MD, Rainer Saffrich, PhD, Annette Ludwig, Mario Schubert, MD, Volker Eckstein, PhD, Anthony D. Ho, MD, PhD

Blood (2009) 114 (22): 1442.

https://doi.org/10.1182/blood.V114.22.1442.1442

Published: 2009

Journal Articles

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Peter Borchmann, Volker Diehl, Helen Goergen, Horst Mueller, Rolf Peter Mueller, Hans T. Eich, Hans Konrad Mueller-Hermelink, Richard Herrmann, MD, Jana Markova, Anthony D. Ho, MD, PhD, Wolfgang Hiddemann, Bernd Doerken, Richard Greil, Andreas Engert, MD

Blood (2009) 114 (22): 717.

https://doi.org/10.1182/blood.V114.22.717.717

Published: 2009

Journal Articles

Molecular Determinants and Functional Characteristics of Leukemic Stem Cells and Their Interaction with the Niche.

Dan Ran, Isabel Taubert, Larissa Pietsch, Patrick Wuchter, MD, Isabelle Hellwig, Rainer Saffrich, PhD, Volker Eckstein, PhD, Anthony D. Ho, MD, PhD and, Mario Schubert, MD

Blood (2009) 114 (22): 1427.

https://doi.org/10.1182/blood.V114.22.1427.1427

Published: 2009

Journal Articles

Centrosomal Clustering – a Novel Therapeutic Target for Multiple Myeloma.

Marc S Raab, MD, Iris Breitkreutz, MD, Blanka Rebacz, PhD, Thomas O Larsen, PhD, Ludmila Wagner, MSc, Patrick Hayden, MD, MRCPath, Anthony D. Ho, MD, PhD, Mads H Clausen, PhD, Hartmut Goldschmidt, MD, Kenneth C. Anderson, MD, Alwin Kraemer, MD

Blood (2009) 114 (22): 300.

https://doi.org/10.1182/blood.V114.22.300.300

Published: 2009

Journal Articles

Clinical Outcome of Patients with Follicular Lymphoma and Bulky Disease After Rituximab-CHOP Immunochemotherapy with and without Consolidating Radiotherapy.

Fabienne McClanahan, MD, Thomas Hielscher, Michael Rieger, MD, Manfred Hensel, MD, PhD, Kai Neben, Jens Hillengass, MD, Klaus Herfarth, MD, PhD, Anthony D. Ho, MD, PhD, Mathias Witzens-Harig, MD

Blood (2009) 114 (22): 2722.

https://doi.org/10.1182/blood.V114.22.2722.2722

Published: 2009

Journal Articles

Hyperdiploidy Is Rare in Patients with AL Amyloidosis – Identification of Major Cytogenetic Groups in Early Monoclonal Plasma Cell Disorders.

Tilmann Bochtler, Ute Hegenbart, MD, Christiane Heiss, Axel Benner, Stephanie Pschowski-Zuck, Désirée Kirn, Kai Neben, Marion Moos, D. Hose, Claus R Bartram, MD, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Anna Jauch, Stefan Schonland

Blood (2009) 114 (22): 2823.

https://doi.org/10.1182/blood.V114.22.2823.2823

Published: 2009

Journal Articles

Prospective Phase II Study Using Dexamethasone Induction Therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation in 30 Patients with Systemic AL Amyloidosis.

Stefan Schonland, Ute Hegenbart, MD, Axel Benner, Jolanta Perz, Tilmann Bochtler, Jörg Beimler, Martin Zeier, Arnt Kristen, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt

Blood (2009) 114 (22): 3401.

https://doi.org/10.1182/blood.V114.22.3401.3401

Published: 2009

Journal Articles

How Much Rituximab Do We Need: A Multicenter, Randomized Trial Comparing 1, 3 or 6 Infusions of Rituximab Combined with 6 Cycles of CHOP Chemotherapy in Untreated Patients with Advanced Follicular Lymphoma (HD2000-Trial).

Fabienne McClanahan, MD, Thomas Hielscher, Michael Rieger, MD, Manfred Hensel, MD, PhD, Martin Bentz, MD, Ingo Schmidt-Wolf, Andreas Kaebisch, MD, Hans-Jürgen Salwender, Heinz Dürk, Hans Juergen Staiger, MD, Thomas Mandel, MD, Kai Neben, MD, Jens Hillengass, MD, Anthony D. Ho, MD, PhD, Mathias Witzens-Harig, MD

Blood (2009) 114 (22): 2687.

https://doi.org/10.1182/blood.V114.22.2687.2687

Published: 2009

Journal Articles

Comparative in-Vitro Evaluation of the Myeloid Toxicity of Pentostatin and the Novel PNP-Inhibitor Forodesine.

Mario Schubert, MD, Christian Wallenwein, Larissa Pietsch, Dan Ran, Isabel Taubert, Katrin Miesala, Patrick Wuchter, MD, Volker Eckstein, PhD, Anthony D. Ho, MD, PhD

Blood (2009) 114 (22): 3766.

https://doi.org/10.1182/blood.V114.22.3766.3766

Published: 2009

Journal Articles

Poor Mobilization of Hematopoietic Stem Cells – Definitions, Incidence, Risk Factors and Impact On Outcome of Autologous Transplantation.

Patrick Wuchter, MD, Dan Ran, Thomas Schmitt, MD, Tom Bruckner, PhD, Mathias Witzens-Harig, MD, Hartmut Goldschmidt, MD, Anthony D. Ho, MD, PhD

Blood (2009) 114 (22): 2153.

https://doi.org/10.1182/blood.V114.22.2153.2153

Published: 2009

Journal Articles

Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients.

Hannes Wandt, MD, Kerstin Schaefer-Eckart, MD, Bettina Pilz, Markus Thalheimer, MD, Anthony D Ho, MD, PhD, Markus Schaich, MD, Martin Kaufmann, MD, Walter E. Aulitzky, MD, Mathias Haenel, MD, Regina Herbst, MD, Gottfried Doelken, MD, Anne Friederike Klenner, MD, Mathias Freund, MD, Christian Junghanss, MD, Gerhard Ehninger, MD

Blood (2009) 114 (22): 20.

https://doi.org/10.1182/blood.V114.22.20.20

Published: 2009

Journal Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

Jens Hillengass, Christian M Zechmann, Tobias Bäuerle, Christiane Heiss, Axel Benner, Kai Neben, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, Stefan Delorme, Thomas M. Moehler

Blood (2008) 112 (11): 2704.

https://doi.org/10.1182/blood.V112.11.2704.2704

Published: 2008

Journal Articles

G-CSF Stimulates Expression of Non-Phosphorylated Stathmin (Oncoprotein, Op18) in Hematopoietic Stem Cells.

Heinrich Lannert, MD, PhD, Thomas Able, Thomas Franz, PhD, Stefan Leicht, PhD, Patrick Wuchter, MD, Angela Lenze, Volker Eckstein, PhD, Rainer Saffrich, PhD, Anthony D. Ho, MD, PhD

Blood (2007) 110 (11): 2215.

https://doi.org/10.1182/blood.V110.11.2215.2215

Published: 2007

Journal Articles

Mesenchymal Stem Cells Regulate the Cell Division Symmetry of Hematopoietic Stem Cells by an Integrin Dependent Mechanism.

Sandra Gottschling, MD, Rainer Saffrich, PhD, Anja Seckinger, Ulf Krause, MD, Katrin Miesala, Kerstin Horsch, Patrick Wuchter, MD, Anthony D. Ho, MD, PhD

Blood (2005) 106 (11): 592.

https://doi.org/10.1182/blood.V106.11.592.592

Published: 2005

Journal Articles

No Influence of Previous Thalidomide Administration on Peripheral Blood Stem Cell Collection in Patients with Multiple Myeloma.

Iris Breitkreutz, MD, Axel Benner, Friedrich W. Cremer, MD, Doris Herrmann, Anthony D. Ho, MD, PhD, Hartmut Goldschmidt, MD

Blood (2004) 104 (11): 4902.

https://doi.org/10.1182/blood.V104.11.4902.4902

Published: 2004

NARROW

Boost Vaccination Improves Humoral Immune Response Against Influenza Virus In Patients With Multiple Myeloma

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV

Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV,

Endothelial Stress in Steroid-Refractory Gvhd: A Burden Statins Cannot Lift

Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results

Cellular Interaction Between Human Mesenchymal Stem Cells and Hematopoietic Stem Cells in 2D- and 3D-Culture-Systems.

Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Molecular Determinants and Functional Characteristics of Leukemic Stem Cells and Their Interaction with the Niche.

Centrosomal Clustering – a Novel Therapeutic Target for Multiple Myeloma.

Clinical Outcome of Patients with Follicular Lymphoma and Bulky Disease After Rituximab-CHOP Immunochemotherapy with and without Consolidating Radiotherapy.

Hyperdiploidy Is Rare in Patients with AL Amyloidosis – Identification of Major Cytogenetic Groups in Early Monoclonal Plasma Cell Disorders.

Prospective Phase II Study Using Dexamethasone Induction Therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation in 30 Patients with Systemic AL Amyloidosis.

How Much Rituximab Do We Need: A Multicenter, Randomized Trial Comparing 1, 3 or 6 Infusions of Rituximab Combined with 6 Cycles of CHOP Chemotherapy in Untreated Patients with Advanced Follicular Lymphoma (HD2000-Trial).

Comparative in-Vitro Evaluation of the Myeloid Toxicity of Pentostatin and the Novel PNP-Inhibitor Forodesine.

Poor Mobilization of Hematopoietic Stem Cells – Definitions, Incidence, Risk Factors and Impact On Outcome of Autologous Transplantation.

Experience with a Therapeutic Platelet Transfusion Strategy in Acute Myeloid Leukemia: Preliminary Results of a Randomized Multicenter Study After Enrolment of 175 Patients.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathological Microcirculation

G-CSF Stimulates Expression of Non-Phosphorylated Stathmin (Oncoprotein, Op18) in Hematopoietic Stem Cells.

Mesenchymal Stem Cells Regulate the Cell Division Symmetry of Hematopoietic Stem Cells by an Integrin Dependent Mechanism.

No Influence of Previous Thalidomide Administration on Peripheral Blood Stem Cell Collection in Patients with Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only